Table 3.

Rates of relapse (clinical and ADAMTS13) within 1 and 2 years according to ADAMTS13 conformation at peak ADAMTS13 activity after acute episode

Within 1 yWithin 2 yOverall
RelapseNo relapseRelapseNo relapseRelapseNo relapse
Open conformation (n = 13) 6 (46%) 7 (54%) 8 (62%) 5 (39%) 8 (61.5%) 5 (38.5%) 
Closed conformation (n = 43) 4 (9%) 39 (91%) 10§ (23%) 33 (77%) 19 (44%) 24 (56%) 
P value; OR; 95% CI .007; 8.4; 2-30.2 .02; 5.3; 1.4-19.1 .35 
Within 1 yWithin 2 yOverall
RelapseNo relapseRelapseNo relapseRelapseNo relapse
Open conformation (n = 13) 6 (46%) 7 (54%) 8 (62%) 5 (39%) 8 (61.5%) 5 (38.5%) 
Closed conformation (n = 43) 4 (9%) 39 (91%) 10§ (23%) 33 (77%) 19 (44%) 24 (56%) 
P value; OR; 95% CI .007; 8.4; 2-30.2 .02; 5.3; 1.4-19.1 .35 

Patients with a closed ADAMTS13 conformation at peak ADAMTS13 activity had significantly lower relapse rates within 1 year (P = .007; OR, 8.4 (2-30.2). Within 2 years, the risk of relapse remains significantly lower in patients with a closed ADAMTS13 conformation. However, there was a higher risk of relapse observed in patients with an open ADAMTS13 conformation, although patient numbers were small.

CI, confidence interval

Two clinical relapses and 4 ADAMTS13 relapses.

Two clinical relapses and 6 ADAMTS13 relapses.

One clinical relapse and 3 ADAMTS13 relapses.

§

One clinical relapse and 9 ADAMTS13 relapses.

or Create an Account

Close Modal
Close Modal